Molecular Analysis for Therapy Choice (NCI MATCH) (EAY131)

Molecular Analysis for Therapy Choice (NCI MATCH) (EAY131)

Trial Category:
Other Solid Tumor
Phase
II
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE

This study looks at tumor already removed from a patient, and identifies certain tumor markers, and aligns a treatment based on the tumor markers.  Patient's tumor must be prescreened in order to advance to a separate treatment study assignment, if one is available.

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members